ZNF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.962200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.083400E-01
Normal-vs-Stage2
3.395200E-01
Normal-vs-Stage3
1.971590E-01
Normal-vs-Stage4
4.323800E-01
Stage1-vs-Stage2
2.970600E-01
Stage1-vs-Stage3
3.909800E-01
Stage1-vs-Stage4
3.845000E-01
Stage2-vs-Stage3
5.289000E-01
Stage2-vs-Stage4
1.053860E-02
Stage3-vs-Stage4
9.707700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.078600E-01
Normal-vs-AfricanAmerican
5.288000E-01
Normal-vs-Asian
2.046400E-01
Caucasian-vs-AfricanAmerican
8.594600E-01
Caucasian-vs-Asian
3.621600E-01
AfricanAmerican-vs-Asian
4.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.859600E-01
Normal-vs-Female
5.429800E-01
Male-vs-Female
2.501000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.877000E-01
Normal-vs-Age(41-60Yrs)
5.207600E-01
Normal-vs-Age(61-80Yrs)
3.796400E-01
Normal-vs-Age(81-100Yrs)
3.856200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.708010E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.075430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.763400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.543000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.217900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.455600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.723500E-02
Normal-vs-Daily Drinker
3.512000E-02
Normal-vs-Weekly Drinker
2.657000E-01
Normal-vs-Occasional Drinker
6.836000E-01
Normal-vs-Social Drinker
6.860200E-01
Non Drinker-vs-Daily Drinker
9.380200E-01
Non Drinker-vs-Weekly Drinker
1.998430E-01
Non Drinker-vs-Occasional Drinker
2.591700E-02
Non Drinker-vs-Social Drinker
3.452200E-02
Daily Drinker-vs-Weekly Drinker
1.285170E-01
Daily Drinker-vs-Occasional Drinker
1.779880E-02
Daily Drinker-vs-Social Drinker
2.210400E-02
Weekly Drinker-vs-Occasional Drinker
3.822600E-01
Weekly Drinker-vs-Social Drinker
3.975200E-01
Occasional Drinker-vs-Social Drinker
9.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.264370E-01
Normal-vs-Grade 2
2.628200E-02
Normal-vs-Grade 3
3.896200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.239800E-01
Grade 1-vs-Grade 3
9.752000E-01
Grade 1-vs-Grade 4
1.264370E-01
Grade 2-vs-Grade 3
4.623400E-01
Grade 2-vs-Grade 4
2.628200E-02
Grade 3-vs-Grade 4
3.896200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.240570E-01
Normal-vs-NonDiabetic
3.820800E-01
Diabetic-vs-NonDiabetic
1.877780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.392300E-02
Normal-vs-NoPancreatitis
3.495400E-01
Pancreatitis-vs-NoPancreatitis
1.433430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.635400E-01
Normal-vs-N1
3.463200E-01
N0-vs-N1
5.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.289400E-01
Normal-vs-TP53-NonMutant
6.171200E-01
TP53-Mutant-vs-TP53-NonMutant
5.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
